Gilead Sciences Inc buy melinda
Start price
27.03.18
/
50%
€67.97
Target price
27.09.18
€80.10
Performance (%)
3.73%
End price
27.09.18
€69.48
Summary
This prediction ended on 27.09.18 with a price of €69.48. With a performance of 3.73%, the BUY prediction by melinda for Gilead Sciences Inc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gilead Sciences Inc | -6.205% | -6.205% | -18.106% | 8.407% |
| iShares Core DAX® | -0.683% | 1.890% | 15.367% | 17.155% |
| iShares Nasdaq 100 | 0.335% | 4.631% | 29.818% | 56.187% |
| iShares Nikkei 225® | -1.486% | -2.361% | 7.668% | 3.633% |
| iShares S&P 500 | -0.523% | 2.324% | 25.460% | 46.452% |
Comments by melinda for this prediction
In the thread Gilead Sciences Inc diskutieren
SektorBiotechnologische und medizinische Forschung
- Hemlibra, die Anti-Hämophilie-Droge der Roche AG, die Anti-HIV-Behandlung von Bikarvary, Gilead Sciences Inc. und die wöchentliche Diabetes-Behandlung von Novo Nordisk werden voraussichtlich bis 2022 einen Umsatz von 3 Milliarden US-Dollar übertreffen .
(Laufzeit überschritten)
Stopped prediction by melinda for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
19.04.20
19.04.20
€80.00
04.11.21
04.11.21
-26.85%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.42
05.03.18
05.03.18
€79.38
19.03.18
19.03.18
2.32%
19.03.18
19.03.18
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€74.64
31.08.17
31.08.17
€81.18
27.12.17
27.12.17
-10.85%
27.12.17
27.12.17
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.45
10.05.16
10.05.16
€84.79
10.11.16
10.11.16
-8.50%
10.11.16
10.11.16
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€12.69
21.07.10
21.07.10
€22.50
22.12.10
22.12.10
9.55%
22.12.10
22.12.10